Humasis, Top Search Ranking... Stock Price -2.56%
Humasis has newly appeared among the top searched stocks.
As of 12:31 PM on the 22nd, Humasis is trading at 6,840 KRW, down 2.56% from the previous day. This represents a 25.97% increase compared to March 11. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 288,462 shares, while foreigners and institutions have net sold 259,386 shares and 25,190 shares, respectively.
On March 19, Humasis became a market issue with a "sharp rise following the MFDS approval of the COVID-19 antigen test kit."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Real-Life Elite League?" Ultra-Luxury Apartments Maple Xi and One Bailey Residents’ Exchange Event Draws Attention
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Mychew, but Nowhere to Be Found... Fears of a 'Pediatric Medical Crisis' as Drug Makers Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
